-
The Cure guitarist and keyboard player Perry Bamonte dies aged 65
-
Draper to miss Australian Open
-
Police arrest suspect after man stabs 3 women in Paris metro
-
Former Montpellier coach Gasset dies at 72
-
Trump's Christmas gospel: bombs, blessings and blame
-
Russia lashes out at Zelensky ahead of new Trump meeting on Ukraine plan
-
Salah helps Egypt beat South Africa and book last-16 place
-
Australia's Ikitau facing lengthy lay-off after shoulder injury
-
Another 1,100 refugees cross into Mauritania from Mali: UN
-
Guardiola proud of Man City players' response to weighty issues
-
Deadly blast hits mosque in Alawite area of Syria's Homs
-
The Jukebox Man on song as Redknapp records 'dream' King George win
-
Liverpool boss Slot says Ekitike reaping rewards for greater physicality
-
Judge jails ex-Malaysian PM Najib for 15 more years after new graft conviction
-
Musona rescues Zimbabwe in AFCON draw with Angola
-
Zelensky to meet Trump in Florida on Sunday
-
'Personality' the key for Celtic boss Nancy when it comes to new signings
-
Arteta eager to avoid repeat of Rice red card against Brighton
-
Nigeria signals more strikes likely in 'joint' US operations
-
Malaysia's former PM Najib convicted in 1MDB graft trial
-
Elusive wild cat feared extinct rediscovered in Thailand
-
Japan govt approves record budget, including for defence
-
Seoul to ease access to North Korean newspaper
-
History-maker Tongue wants more of the same from England attack
-
Australia lead England by 46 after 20 wickets fall on crazy day at MCG
-
Asia markets edge up as precious metals surge
-
Twenty wickets fall on day one as Australia gain edge in 4th Ashes Test
-
'No winner': Kosovo snap poll unlikely to end damaging deadlock
-
Culture being strangled by Kosovo's political crisis
-
Main contenders in Kosovo's snap election
-
Australia all out for 152 as England take charge of 4th Ashes Test
-
Boys recount 'torment' at hands of armed rebels in DR Congo
-
Inside Chernobyl, Ukraine scrambles to repair radiation shield
-
Bondi victims honoured as Sydney-Hobart race sets sail
-
North Korea's Kim orders factories to make more missiles in 2026
-
Palladino's Atalanta on the up as Serie A leaders Inter visit
-
Hooked on the claw: how crane games conquered Japan's arcades
-
Shanghai's elderly waltz back to the past at lunchtime dance halls
-
Japan govt approves record 122 trillion yen budget
-
US launches Christmas Day strikes on IS targets in Nigeria
-
Australia reeling on 72-4 at lunch as England strike in 4th Ashes Test
-
Too hot to handle? Searing heat looming over 2026 World Cup
-
Packers clinch NFL playoff spot as Lions lose to Vikings
-
Guinea's presidential candidates hold final rallies before Sunday's vote
-
TGI Solar Power Group Inc. and Genesys Info X Announce Strategic Partnership to Launch FUSED88.com, a Next-Generation AI & ASI Driven Management Platform
-
When Capital Risk Disappears: The New Valuation Lens for SMX
-
President Trump's Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else
-
Calvin B. Taylor Bankshares, Inc. Reports Third Quarter Financial Results and Announces New Stock Repurchase Program
-
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
Japan drugmaker reports two more deaths in supplement scare
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.
The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.
Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.
"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.
It added it had been told separately that another person who had used Choleste Help in recent years had died.
"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.
"However, we decided to make this report public from the viewpoint of prompt disclosure."
Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.
Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.
The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.
Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".
The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.
Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.
The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.
Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".
But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.
C.Garcia--AMWN